chr8-81283416-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001444.3(FABP5):āc.130A>Gā(p.Ile44Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000484 in 1,611,370 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001444.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FABP5 | NM_001444.3 | c.130A>G | p.Ile44Val | missense_variant | 2/4 | ENST00000297258.11 | NP_001435.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FABP5 | ENST00000297258.11 | c.130A>G | p.Ile44Val | missense_variant | 2/4 | 1 | NM_001444.3 | ENSP00000297258 | P1 | |
FABP5 | ENST00000396359.1 | c.28A>G | p.Ile10Val | missense_variant | 2/4 | 5 | ENSP00000379647 | |||
FABP5 | ENST00000481695.1 | n.91A>G | non_coding_transcript_exon_variant | 1/2 | 2 | |||||
FABP5 | ENST00000486269.1 | n.389A>G | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152242Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000112 AC: 28AN: 249170Hom.: 0 AF XY: 0.0000965 AC XY: 13AN XY: 134672
GnomAD4 exome AF: 0.0000432 AC: 63AN: 1459010Hom.: 0 Cov.: 30 AF XY: 0.0000372 AC XY: 27AN XY: 725626
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152360Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74510
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.130A>G (p.I44V) alteration is located in exon 2 (coding exon 2) of the FABP5 gene. This alteration results from a A to G substitution at nucleotide position 130, causing the isoleucine (I) at amino acid position 44 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at